Company: LENZ
Filing Date: 2025-11-05
Form Type: 10-Q
Source: 0001815776-25-000071
Chunk: 329

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-11-05
Form: 10-Q
Item: Part II, Item 6
Chunk 329
---
apeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

81

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

LENZ THERAPEUTICS, INC.Dated: November 5, 2025By:/s/ Evert SchimmelpenninkName:Evert SchimmelpenninkTitle:Chief Executive Officer(Principal Executive Officer)Dated: November 5, 2025By:/s/ Daniel ChevallardName:Daniel ChevallardTitle:Chief Financial Officer(Principal Financial and Accounting Officer)

82